1. Home
  2. WKHS vs IGC Comparison

WKHS vs IGC Comparison

Compare WKHS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKHS
  • IGC
  • Stock Information
  • Founded
  • WKHS 2007
  • IGC 2005
  • Country
  • WKHS United States
  • IGC United States
  • Employees
  • WKHS N/A
  • IGC N/A
  • Industry
  • WKHS Auto Manufacturing
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKHS Consumer Discretionary
  • IGC Health Care
  • Exchange
  • WKHS Nasdaq
  • IGC Nasdaq
  • Market Cap
  • WKHS 33.5M
  • IGC 29.4M
  • IPO Year
  • WKHS N/A
  • IGC N/A
  • Fundamental
  • Price
  • WKHS $0.54
  • IGC $0.32
  • Analyst Decision
  • WKHS Sell
  • IGC Strong Buy
  • Analyst Count
  • WKHS 3
  • IGC 2
  • Target Price
  • WKHS $5.75
  • IGC $3.75
  • AVG Volume (30 Days)
  • WKHS 2.9M
  • IGC 387.0K
  • Earning Date
  • WKHS 03-11-2025
  • IGC 02-18-2025
  • Dividend Yield
  • WKHS N/A
  • IGC N/A
  • EPS Growth
  • WKHS N/A
  • IGC N/A
  • EPS
  • WKHS N/A
  • IGC N/A
  • Revenue
  • WKHS $9,097,780.00
  • IGC $1,183,000.00
  • Revenue This Year
  • WKHS N/A
  • IGC N/A
  • Revenue Next Year
  • WKHS $80.00
  • IGC $13.38
  • P/E Ratio
  • WKHS N/A
  • IGC N/A
  • Revenue Growth
  • WKHS N/A
  • IGC N/A
  • 52 Week Low
  • WKHS $0.46
  • IGC $0.27
  • 52 Week High
  • WKHS $8.18
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • WKHS 35.59
  • IGC 37.57
  • Support Level
  • WKHS $0.46
  • IGC $0.31
  • Resistance Level
  • WKHS $0.55
  • IGC $0.37
  • Average True Range (ATR)
  • WKHS 0.06
  • IGC 0.02
  • MACD
  • WKHS -0.00
  • IGC -0.00
  • Stochastic Oscillator
  • WKHS 29.42
  • IGC 18.18

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: